Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas

OBJECTIVE: Administration of targeted therapies provides a promising treatment strategy for urachal adenocarcinoma (UrC) or primary bladder adenocarcinoma (PBAC); however, the selection of appropriate drugs remains difficult. Here, we aimed to establish a routine compatible methodological pipeline f...

Descripción completa

Detalles Bibliográficos
Autores principales: Varadi, Melinda, Nagy, Nikolett, Reis, Henning, Hadaschik, Boris, Niedworok, Christian, Modos, Orsolya, Szendroi, Attila, Ablat, Jason, Black, Peter C., Keresztes, David, Csizmarik, Anita, Olah, Csilla, Gaisa, Nadine T., Kiss, Andras, Timar, Jozsef, Toth, Erika, Csernak, Erzsebet, Gerstner, Arpad, Mittal, Vinay, Karkampouna, Sofia, Kruithof de Julio, Marianna, Gyorffy, Balazs, Bedics, Gabor, Rink, Michael, Fisch, Margit, Nyirady, Peter, Szarvas, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134276/
https://www.ncbi.nlm.nih.gov/pubmed/36670542
http://dx.doi.org/10.1002/cam4.5639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134276/
https://www.ncbi.nlm.nih.gov/pubmed/36670542
http://dx.doi.org/10.1002/cam4.5639

Ejemplares similares